This Week in Science

In Science this week, a team from Memorial Sloan-Kettering Cancer Center reports on its discovery of genetic mutations that improve the clinical response to the cancer drug everolimus. The researchers sequenced the genome of a metastatic bladder cancer patient who had shown a complete and long-lasting response to the drug, which targets the signaling protein mTORC1.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in Nature

This Week in PNAS

This Week in Cell

The Big Prize

More than Once

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.